BR0009666A - Adenovìrus recombinante e mutante derivado de adenovìrus bovino tipo 1 - Google Patents

Adenovìrus recombinante e mutante derivado de adenovìrus bovino tipo 1

Info

Publication number
BR0009666A
BR0009666A BR0009666-0A BR0009666A BR0009666A BR 0009666 A BR0009666 A BR 0009666A BR 0009666 A BR0009666 A BR 0009666A BR 0009666 A BR0009666 A BR 0009666A
Authority
BR
Brazil
Prior art keywords
adenoviruses
mutant
recombinant
present
derived
Prior art date
Application number
BR0009666-0A
Other languages
English (en)
Inventor
Christina H Chiang
Mark D Cochran
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of BR0009666A publication Critical patent/BR0009666A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Patente de Invenção: "ADENOVìRUS RECOMBINANTE E MUTANTE DERIVADO DE ADENOVìRUS BOVINO TIPO 1". A presente invenção provê vetores virais. Em uma modalidade, a presente invenção provê adenovírus bovinos mutantes e recombinantes tendo uma deleção e/ou inserção de DNA na região de gene inicial 4 (E4). Em uma outra modalidade, a presente invenção provê um vírus adenovírus bovino 1 mutante e recombinante tendo uma deleção e/ou inserção de DNA na região de gene inicial 3 (E3). A presente invenção também contempla o uso dos vetores virais para vacinação, terapia genética ou outras aplicações como apropriado.
BR0009666-0A 1999-04-09 2000-04-07 Adenovìrus recombinante e mutante derivado de adenovìrus bovino tipo 1 BR0009666A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28993099A 1999-04-09 1999-04-09
PCT/US2000/009459 WO2000061773A1 (en) 1999-04-09 2000-04-07 Recombinant and mutant adenoviruses derived of bovine adenovirus type 1

Publications (1)

Publication Number Publication Date
BR0009666A true BR0009666A (pt) 2002-02-05

Family

ID=23113786

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0009666-0A BR0009666A (pt) 1999-04-09 2000-04-07 Adenovìrus recombinante e mutante derivado de adenovìrus bovino tipo 1

Country Status (7)

Country Link
EP (1) EP1169464A1 (pt)
JP (1) JP2002541815A (pt)
AU (1) AU4220600A (pt)
BR (1) BR0009666A (pt)
CA (1) CA2365911A1 (pt)
MX (1) MXPA01010148A (pt)
WO (1) WO2000061773A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7906311B2 (en) 2002-03-20 2011-03-15 Merial Limited Cotton rat lung cells for virus culture
US7205398B2 (en) 2002-05-24 2007-04-17 Schering-Plough Animal Health Corporation Eta-1 gene and methods for use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5820868A (en) * 1993-12-09 1998-10-13 Veterinary Infectious Disease Organization Recombinant protein production in bovine adenovirus expression vector system
FR2725726B1 (fr) * 1994-10-17 1997-01-03 Centre Nat Rech Scient Vecteurs viraux et utilisation en therapie genique
DE69740033D1 (de) * 1996-07-03 2010-12-09 Merial Inc Rekombinanter hunde-adenovirus 2 (cav2), welcher exogene dna enthält

Also Published As

Publication number Publication date
CA2365911A1 (en) 2000-10-19
AU4220600A (en) 2000-11-14
JP2002541815A (ja) 2002-12-10
EP1169464A1 (en) 2002-01-09
WO2000061773A1 (en) 2000-10-19
MXPA01010148A (es) 2003-07-14

Similar Documents

Publication Publication Date Title
DK0698108T3 (da) Adenovirale vektorer af animalsk oprindelse og deres anvendelse ved genterapi
FI961755A (fi) Yhdistelmäadenovirusvektori ja menetelmiä sen käyttämiseksi
FR2704556B1 (fr) Virus recombinants et leur utilisation en thérapie génique.
HK1214298A1 (zh) 用於疫苗和基因治療的重組流感病毒
KR20030025907A (ko) 카세인 유도 펩타이드 및 이들의 치료 용도
EP1005376A4 (en) METHODS AND COMPOSITIONS FOR USE IN GENE THERAPY IN THE TREATMENT OF HEMOPHILIA
BR0014155A (pt) Prevenção da miocardite, do aborto e da infecção intrauterina, associados com o circovìrus-2 porcino
MY150893A (en) Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
BR9803960A (pt) Gene de desidrogenase de d-sorbitol.
BR0009666A (pt) Adenovìrus recombinante e mutante derivado de adenovìrus bovino tipo 1
KR20040078639A (ko) 카세인 유도 펩타이드 및 이들의 치료 용도
GB2359083A (en) Mutant herpes simplex viruses and uses thereof
BR0012020A (pt) Proteìna, e, dna
HUP9904201A1 (hu) Génterápiában használható, egy exogén nukleinsavat genomjában beépítve tartalmazó rekombináns vírus és egy nem virális és nem plazmid transzfektáló szer kombinációját tartalmazó transzfektáló készítmény
BR9909388A (pt) Uso de pelo menos uma leishmania cisteìna proteinase, vacina, proteìna cpa do l. infantum, genes cpa e cpb do l. infantum, cpa ou cpb, e, uso das proteìnas cpa e/ou cpb ou das sequências de ácido nucléico do cpa e/ou cpb
WO2000022136A3 (en) Recombinant e1a deleted adenoviral vectors
BR9914013A (pt) Vìrus celo recombinante e dna de vìrus celo
TR200002611T2 (tr) Beta-lipotropin ve kullanımları
FI964784A (fi) Yhdistelmä-DNA-viruksia, valmistus ja käyttö geeniterapiassa

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired